Mannitol (20%)

DRUG4 trials

Conditions

Breast Cancer Early Stage Breast Cancer (Stage 1-3)DexmedetomidineICP (Intracranial Pressure) IncreaseIntra-dialytic HypotensionOptic Nerve Sheath Diameter MeasurementTBI (Traumatic Brain Injury)

Phase 1

A Dose-Image Optimization Trial Evaluating Mannitol and Voluven as Adjuncts for Indocyanine Green

Enrolling by invitationNCT06768268

National Taiwan University HospitalBreast Cancer Early Stage Breast Cancer (Stage 1-3)

Start: 2025-01-01End: 2025-12-31Target: 30Updated: 2025-04-16

Phase 2

Mannitol - Potential Role in Hemodialysis Initiation for Reduction of Intra-dialytic Hypotension

CompletedNCT01520207

Brigham and Women's HospitalIntra-dialytic Hypotension

Start: 2012-05-31End: 2018-12-31Updated: 2019-01-30

Adding Dexmedetomidine to Mannitol to Attenuate the Increase of Intracranial Pressure

CompletedNCT07064720

Cairo UniversityDexmedetomidine

Start: 2024-07-12End: 2026-01-15Updated: 2026-01-21

Unknown Phase

Comparison of Hyperosmolar Agent in Reduction of Increased Intracranial Pressure in Patients With Traumatic Brain Injury Using Ultrasonography

Not yet recruitingNCT07786324

Assiut UniversityICP (Intracranial Pressure) Increase, Optic Nerve Sheath Diameter Measurement, TBI (Traumatic Brain Injury)

Start: 2026-10-01End: 2029-09-30Target: 100Updated: 2026-08-25

Related Papers

Higher <scp>NT‐proBNP</scp> levels and the risk of intradialytic hypotension at hemodialysis initiation

Hemodialysis International2023-10-2411 citations

Hypertonic Mannitol for the Prevention of Intradialytic Hypotension: A Randomized Controlled Trial.